2016 annual financial data
Heron Therapeutics 2016 Net margin
Direct answer
Net margin was -13,537.37%.
Operating income was -170,915,000 USD and net income was -173,143,000 USD.
Operating cash flow was -134,097,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,279,000 USD
- Operating income
- -170,915,000 USD
- Net income
- -173,143,000 USD
- Operating cash flow
- -134,097,000 USD